FASEB Revenue and Competitors

Location

N/A

Total Funding

NonProfit

Industry

Estimated Revenue & Valuation

  • FASEB's estimated annual revenue is currently $15M per year.(i)
  • FASEB's estimated revenue per employee is $141,509

Employee Data

  • FASEB has 106 Employees.(i)
  • FASEB grew their employee count by 1% last year.

FASEB's People

NameTitleEmail/Phone
1
Deputy Executive Director & Director, Office Public AffairsReveal Email/Phone
2
Director, FASEB Open Science and Research IntegrityReveal Email/Phone
3
Director, Science PolicyReveal Email/Phone
4
Executive Director and CEOReveal Email/Phone
5
Director, Office Scientific Meetings and ConferencesReveal Email/Phone
6
Director, Governance and Leadership DevelopmentReveal Email/Phone
7
Associate Director Science PolicyReveal Email/Phone
8
Senior Conference ManagerReveal Email/Phone
9
Senior Conference ManagerReveal Email/Phone
10
Grants and Sponsorship ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A2567%N/AN/A
#2
$15M1948%N/AN/A
#3
$35M743%N/AN/A
#4
N/A3210%N/AN/A
#5
$7.5M637%N/AN/A
#6
N/A6215%N/AN/A
#7
N/A3-25%N/AN/A
#8
$3.5M29-9%N/AN/A
#9
$15M2226%N/AN/A
#10
$15M8228%N/AN/A
Add Company

What Is FASEB?

Founded in 1912, the Federation of American Societies for Experimental Biology (FASEB) was originally created by three independent scientific organizations to provide a forum in which to hold educational meetings, develop publications, and disseminate biological research results. What started as a small group of dedicated scientists has grown to be the nation’s largest coalition of biomedical researchers, representing 23 scientific societies and over 100,000 researchers from around the world. FASEB is now recognized as the policy voice of biological and biomedical researchers.

keywords:N/A

N/A

Total Funding

106

Number of Employees

$15M

Revenue (est)

1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$22.3M10622%N/A
#2
$27.9M1101%N/A
#3
$17.9M110-19%N/A
#4
$30M1118%N/A
#5
$16.7M111-5%N/A